{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:15:42Z","timestamp":1791357342083,"version":"4.3.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012779","name":"R\u00e9seau Qu\u00e9b\u00e9cois de Recherche sur les M\u00e9dicaments","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ajog.2015.01.034","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T12:59:06Z","timestamp":1422449946000},"page":"795.e1-795.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Sertraline use during pregnancy and the risk of major malformations"],"prefix":"10.1016","volume":"212","author":[{"given":"Anick","family":"B\u00e9rard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Sheehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2015.01.034_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.01.033","article-title":"Increasing use of antidepressants in pregnancy","volume":"196","author":"Cooper","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.034_bib2","doi-asserted-by":"crossref","first-page":"e63034","DOI":"10.1371\/journal.pone.0063034","article-title":"Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study","volume":"8","author":"Jimenez-Solem","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2015.01.034_bib3","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1471-0528.2007.01387.x","article-title":"Prevalence and predictors of antidepressant use in a cohort of pregnant women","volume":"114","author":"Ramos","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2015.01.034_bib4","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects","volume":"356","author":"Alwan","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.01.034_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/bdrb.20099","article-title":"First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage","volume":"80","author":"Berard","year":"2007","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.ajog.2015.01.034_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/CLEP.S9256","article-title":"Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis","volume":"2","author":"Kornum","year":"2010","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ajog.2015.01.034_bib7","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.01.034_bib8","doi-asserted-by":"crossref","first-page":"b3569","DOI":"10.1136\/bmj.b3569","article-title":"Selective serotonin reuptake inhibitors in\u00a0pregnancy and congenital malformations: population-based cohort study","volume":"339","author":"Pedersen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2015.01.034_bib9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.ede.0000239581.76793.ae","article-title":"Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations","volume":"17","author":"Wogelius","year":"2006","journal-title":"Epidemiology"},{"key":"10.1016\/j.ajog.2015.01.034_bib10","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects","volume":"370","author":"Huybrechts","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.01.034_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/AOG.0b013e318220edcc","article-title":"Selective serotonin reuptake inhibitors and risk for major congenital anomalies","volume":"118","author":"Malm","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.034_bib12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/pds.3462","article-title":"Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD","volume":"22","author":"Margulis","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2015.01.034_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/JCP.0b013e3182490eaf","article-title":"Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study","volume":"32","author":"Nordeng","year":"2012","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.ajog.2015.01.034_bib14","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data","volume":"40","author":"Reis","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.ajog.2015.01.034_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/bdra.20773","article-title":"Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy","volume":"91","author":"Colvin","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2015.01.034_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/bdrb.20144","article-title":"Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data","volume":"83","author":"Oberlander","year":"2008","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.ajog.2015.01.034_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bmjopen-2012-001148","article-title":"Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study","volume":"2","author":"Jimenez-Solem","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2015.01.034_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/pds.1558","article-title":"Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women","volume":"17","author":"Vilain","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2015.01.034_bib19","doi-asserted-by":"crossref","first-page":"e93870","DOI":"10.1371\/journal.pone.0093870","article-title":"The Quebec pregnancy cohort\u2013prevalence of medication use during gestation and pregnancy outcomes","volume":"9","author":"Berard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2015.01.034_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2174\/15748863112079990011","article-title":"Epidemiology of major congenital malformations with specific focus on teratogens","volume":"8","author":"Chaabane","year":"2013","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.ajog.2015.01.034_bib21","series-title":"Drugs in pregnancy and lactation","author":"Briggs","year":"2011"},{"key":"10.1016\/j.ajog.2015.01.034_bib22","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/j.1471-0528.2009.02377.x","article-title":"Prescriptions filled during pregnancy for drugs with the potential of fetal harm","volume":"116","author":"Kulaga","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2015.01.034_bib23","first-page":"155","article-title":"Can we rely on pharmacy claims databases to ascertain maternal use of medications during pregnancy?","volume":"22(Suppl1)","author":"Jobin-Gervais","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2015.01.034_bib24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/pds.3446","article-title":"Validity of congenital malformation diagnostic codes recorded in Quebec's administrative databases","volume":"22","author":"Blais","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"Suppl","key":"10.1016\/j.ajog.2015.01.034_bib25","first-page":"153","article-title":"Registries of congenital anomalies: EUROCAT","volume":"101","author":"Lechat","year":"1993","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.ajog.2015.01.034_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bdra.20643","article-title":"Paroxetine exposure during pregnancy and the risk of cardiac malformations: what is the evidence?","volume":"88","author":"Berard","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2015.01.034_bib27","doi-asserted-by":"crossref","first-page":"e92778","DOI":"10.1371\/journal.pone.0092778","article-title":"Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis","volume":"9","author":"Huybrechts","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2015.01.034_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijdevneu.2003.10.002","article-title":"Serotonin and its transporter on proliferation of fetal heart cells","volume":"21","author":"Sari","year":"2003","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.ajog.2015.01.034_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00208198","article-title":"Serotonin and morphogenesis: transient expression of serotonin uptake and binding protein during craniofacial morphogenesis in the mouse","volume":"187","author":"Shuey","year":"1993","journal-title":"Anat Embryol (Berl)"},{"key":"10.1016\/j.ajog.2015.01.034_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/tera.1420470609","article-title":"Serotonin and cardiac morphogenesis in the\u00a0mouse embryo","volume":"47","author":"Yavarone","year":"1993","journal-title":"Teratology"},{"key":"10.1016\/j.ajog.2015.01.034_bib31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.reprotox.2011.09.004","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and heart defects: potential mechanisms for the observed associations","volume":"32","author":"Sadler","year":"2011","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2015.01.034_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1096-9926(199907)60:1<33::AID-TERA9>3.0.CO;2-X","article-title":"Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. European Medicine and Pregnancy Group","volume":"60","author":"De Jong van den Berg","year":"1999","journal-title":"Teratology"},{"key":"10.1016\/j.ajog.2015.01.034_bib33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1503\/cmaj.091208","article-title":"Use of antidepressants during pregnancy and the risk of spontaneous abortion","volume":"182","author":"Nakhai-Pour","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.ajog.2015.01.034_bib34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1701-2163(16)34177-9","article-title":"Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database","volume":"31","author":"Einarson","year":"2009","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2015.01.034_bib35","first-page":"e360","article-title":"Validity of perinatal pharmacoepidemiologic studies using data from the RAMQ administrative database","volume":"16","author":"Berard","year":"2009","journal-title":"Can J Clin Pharmacol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815000903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815000903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:06:23Z","timestamp":1767171983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815000903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0002937815000903"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.01.034","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sertraline use during pregnancy and the risk of major malformations","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}